Term ends Feb 22, 2039 · Low confidence
20-year base term ends Feb 22, 2039
Held by Entrada Therapeutics, Inc.
Filed Mar 28, 2024 as application 18/620,636 · Granted Aug 4, 2026
Base term, 20 years from filing
Today
2019
2039
Clock starts
Feb 22, 2019
Feb 22, 2019
Term ends
Feb 22, 2039
Feb 22, 2039
Granted
Aug 4, 2026
Aug 4, 2026
base term
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 11,168,310, US 11,987,821, to Feb 22, 2039. The term already ends on or before that date, so the cap shortened nothing.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 0 of 3 maintenance fees are paid so far. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 22, 2019, when application PCT/US2019/019117, the earliest non-provisional in its chain, was filed (this one was filed Mar 28, 2024); a parent in its chain could not be resolved (the next row) | Feb 22, 2039 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,168,310, US 11,987,821) | resolves to Feb 22, 2039, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Further caveats on record | The record names parents not resolved: 17495238, 16821018, PCTUS2019019117 | Low confidence overall | Low confidence |
| Computed term end | The steps above, in order | Feb 22, 2039 | Low confidence |
This family
| Application PCT/US2019/019117 | PCT application no patent term | no patent term |
| US 11,168,310 | In force Feb 2039 | Feb 2039 |
| US 11,987,821 | In force Aug 2039 | Aug 2039 |
| US 12,698,482 | this patent Feb 2039 | Feb 2039 |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 8, 2025 Reel 70764, frame 767 | Ruth, Jason; Tartaglia, Lou | 5AM Venture Management, LLC | Assignment of Assignor's Interest |
| Apr 8, 2025 Reel 70764, frame 883 | 5AM Venture Management, LLC | Entrada Therapeutics, Inc. | Assignment of Assignor's Interest |
| Apr 8, 2025 Reel 70764, frame 952 | Sethuraman, Natarajan; Pei, Dehua; Qian, Ziqing | Entrada Therapeutics, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Feb 2039
Term ends Feb 22, 2039. Maintenance fees still fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 11,168,310, US 11,987,821, ends no earlier than this term, so it caps nothing.
Citations
We have no citation count for this patent yet. That is not the same as never having been cited.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.